Literature DB >> 1676097

Tacrine in Alzheimer's disease.

S A Eagger, R Levy, B J Sahakian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1676097     DOI： 10.1016/0140-6736(91)90035-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

Review 2.  The ethics of elective psychopharmacology.

Authors:  Ahmed D Mohamed; Barbara J Sahakian
Journal:  Int J Neuropsychopharmacol       Date:  2011-03-14       Impact factor: 5.176

3.  Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity.

Authors:  Yulong Lin; Yalin Wang; Jie Lv; Nannan Wang; Jing Wang; Meng Li
Journal:  Int J Nanomedicine       Date:  2019-07-26

Review 4.  Innovative solutions to novel drug development in mental health.

Authors:  T R Insel; V Voon; J S Nye; V J Brown; B M Altevogt; E T Bullmore; G M Goodwin; R J Howard; D J Kupfer; G Malloch; H M Marston; D J Nutt; T W Robbins; S M Stahl; M D Tricklebank; J H Williams; B J Sahakian
Journal:  Neurosci Biobehav Rev       Date:  2013-04-03       Impact factor: 8.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.